{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,21]],"date-time":"2024-06-21T05:51:59Z","timestamp":1718949119323},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2008,10,1]],"date-time":"2008-10-01T00:00:00Z","timestamp":1222819200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Nucl Med"],"published-print":{"date-parts":[[2008,10]]},"DOI":"10.1007\/s12149-008-0181-9","type":"journal-article","created":{"date-parts":[[2008,11,3]],"date-time":"2008-11-03T05:04:00Z","timestamp":1225688640000},"page":"645-651","source":"Crossref","is-referenced-by-count":9,"title":["Clinical significance of 18F-FDG uptake by primary sites in patients with diffuse large B cell lymphoma in the head and neck: a pilot study"],"prefix":"10.1007","volume":"22","author":[{"given":"Byung Hyun","family":"Byun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Im Il","family":"Na","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gi Jeong","family":"Cheon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hye Jin","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyeong Min","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seung-Sook","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Baek-Yeol","family":"Ryoo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chang Woon","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sang Moo","family":"Lim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sung Hyun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,11,4]]},"reference":[{"key":"181_CR1","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/0277-5379(91)90081-N","volume":"27","author":"F. d\u2019Amore","year":"1991","unstructured":"d\u2019Amore F, Christensen BE, Brincker H, Pedersen NT, Thorling K, Hastrup J, et al. Clinicopathological features and prognostic factors in extranodal non-Hodgkin lymphomas. Danish LYFO Study Group. Eur J Cancer 1991;27:1201\u20131208.","journal-title":"Eur J Cancer"},{"key":"181_CR2","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1002\/(SICI)1097-0215(19970917)72:6<923::AID-IJC1>3.0.CO;2-R","volume":"72","author":"R. Newton","year":"1997","unstructured":"Newton R, Ferlay J, Beral V, Devesa SS. The epidemiology of non-Hodgkin\u2019s lymphoma: comparison of nodal and extranodal sites. Int J Cancer 1997;72:923\u2013930.","journal-title":"Int J Cancer"},{"key":"181_CR3","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1093\/annonc\/mdg004","volume":"14","author":"A.D. Krol","year":"2003","unstructured":"Krol AD, le Cessie S, Snijder S, Kluin-Nelemans JC, Kluin PM, Noordijk EM. Primary extranodal non-Hodgkin\u2019s lymphoma (NHL): the impact of alternative definitions tested in the Comprehensive Cancer Centre West population-based NHL registry. Ann Oncol 2003;14:131\u2013139.","journal-title":"Ann Oncol"},{"key":"181_CR4","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1023\/A:1008313229892","volume":"10","author":"E. Zucca","year":"1999","unstructured":"Zucca E, Roggero E, Bertoni F, Conconi A, Cavalli F. Primary extranodal non-Hodgkin\u2019s lymphomas: Part 2. Head and neck, central nervous system and other less common sites. Ann Oncol 1999;10:1023\u20131033.","journal-title":"Ann Oncol"},{"key":"181_CR5","first-page":"4655","volume":"18","author":"T. Economopoulos","year":"1998","unstructured":"Economopoulos T, Fountzilas G, Kostourou A, Daniilidis J, Pavlidis N, Andreopoulou H, et al. Primary extranodal non Hodgkin\u2019s lymphoma of the head and neck in adults: a clinicopathological comparison between tonsillar and non tonsillar lymphomas (Hellenic co-Operative Oncology Group). Anticancer Res 1998;18:4655\u20134660.","journal-title":"Anticancer Res"},{"key":"181_CR6","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1002\/hed.1077","volume":"23","author":"A.A. Ezzat","year":"2001","unstructured":"Ezzat AA, Ibrahim EM, El Weshi AN, Khafaga YM, AlJurf M, Martin JM, et al. Localized non-Hodgkin\u2019s lymphoma of Waldeyer\u2019s ring: clinical features, management, and prognosis of 130 adult patients. Head Neck 2001;23:547\u2013558.","journal-title":"Head Neck"},{"key":"181_CR7","first-page":"343","volume":"38","author":"C.K. Hoh","year":"1997","unstructured":"Hoh CK, Glaspy J, Rosen P, Dahlbom M, Lee SJ, Kunkel L, et al. Whole-body FDG-PET imaging for staging of Hodgkin\u2019s disease and lymphoma. J Nucl Med 1997;38:343\u2013348.","journal-title":"J Nucl Med"},{"key":"181_CR8","doi-asserted-by":"crossref","first-page":"4652","DOI":"10.1200\/JCO.2005.01.891","volume":"23","author":"M.E. Juweid","year":"2005","unstructured":"Juweid ME, Wiseman GA, Vose JM, Ritchie JM, Menda Y, Wooldridge JE, et al. Response assessment of aggressive non-Hodgkin\u2019s lymphoma by integrated International Workshop Criteria and fluorine-18-fluorodeoxyglucose positron emission tomography. J Clin Oncol 2005;23:4652\u20134661.","journal-title":"J Clin Oncol"},{"key":"181_CR9","doi-asserted-by":"crossref","first-page":"4643","DOI":"10.1200\/JCO.2005.12.072","volume":"23","author":"H. Schoder","year":"2005","unstructured":"Schoder H, Noy A, Gonen M, Weng L, Green D, Erdi YE, et al. Intensity of 18fluorodeoxyglucose uptake in positron emission tomography distinguishes between indolent and aggressive non-Hodgkin\u2019s lymphoma. J Clin Oncol 2005;23:4643\u20134651.","journal-title":"J Clin Oncol"},{"key":"181_CR10","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1182\/blood-2005-01-0272","volume":"106","author":"C. Haioun","year":"2005","unstructured":"Haioun C, Itti E, Rahmouni A, Brice P, Rain JD, Belhadj K, et al. [18F]fluoro-2-deoxy-d-glucose positron emission tomography (FDG-PET) in aggressive lymphoma: an early prognostic tool for predicting patient outcome. Blood 2005;106:1376\u20131381.","journal-title":"Blood"},{"key":"181_CR11","doi-asserted-by":"crossref","first-page":"3522","DOI":"10.1182\/blood.V86.9.3522.bloodjournal8693522","volume":"86","author":"M. Lapela","year":"1995","unstructured":"Lapela M, Leskinen S, Minn HR, Lindholm P, Klemi PJ, Soderstrom KO, et al. Increased glucose metabolism in untreated non-Hodgkin\u2019s lymphoma: a study with positron emission tomography and fluorine-18-fluorodeoxyglucose. Blood 1995;86:3522\u20133527.","journal-title":"Blood"},{"key":"181_CR12","doi-asserted-by":"crossref","first-page":"3201","DOI":"10.1200\/JCO.1999.17.10.3201","volume":"17","author":"J.F. Vansteenkiste","year":"1999","unstructured":"Vansteenkiste JF, Stroobants SG, Dupont PJ, De Leyn PR, Verbeken EK, Deneffe GJ, et al. Prognostic importance of the standardized uptake value on (18)F-fluoro-2-deoxy-glucosepositron emission tomography scan in non-small-cell lung cancer: an analysis of 125 cases. Leuven Lung Cancer Group. J Clin Oncol 1999;17:3201\u20133206.","journal-title":"J Clin Oncol"},{"key":"181_CR13","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1093\/annonc\/mdl180","volume":"17","author":"L.F. Geus-Oei de","year":"2006","unstructured":"de Geus-Oei LF, Wiering B, Krabbe PF, Ruers TJ, Punt CJ, Oyen WJ. FDG-PET for prediction of survival of patients with metastatic colorectal carcinoma. Ann Oncol 2006;17:1650\u20131655.","journal-title":"Ann Oncol"},{"key":"181_CR14","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.2967\/jnumed.107.042093","volume":"48","author":"C. Lin","year":"2007","unstructured":"Lin C, Itti E, Haioun C, Petegnief Y, Luciani A, Dupuis J, et al. Early 18F-FDG PET for prediction of prognosis in patients with diffuse large B-cell lymphoma: SUVbased assessment versus visual analysis. J Nucl Med 2007;48:1626\u20131632.","journal-title":"J Nucl Med"},{"key":"181_CR15","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1002\/(SICI)1097-0142(19980615)82:12<2439::AID-CNCR19>3.0.CO;2-Q","volume":"82","author":"T.S. Mok","year":"1998","unstructured":"Mok TS, Steinberg J, Chan AT, Yeo WM, Hui P, Leung TW, et al. Application of the international prognostic index in a study of Chinese patients with non-Hodgkin\u2019s lymphoma and a high incidence of primary extranodal lymphoma. Cancer 1998;82:2439\u20132448.","journal-title":"Cancer"},{"key":"181_CR16","doi-asserted-by":"crossref","first-page":"3835","DOI":"10.1200\/JCO.1999.17.12.3835","volume":"17","author":"N.L. Harris","year":"1999","unstructured":"Harris NL, Jaffe ES, Diebold J, Flandrin G, Muller-Hermelink HK, Vardiman J, et al. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997. J Clin Oncol 1999;17:3835\u20133849.","journal-title":"J Clin Oncol"},{"key":"181_CR17","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1182\/blood-2002-04-1286","volume":"101","author":"L. Colomo","year":"2003","unstructured":"Colomo L, Lopez-Guillermo A, Perales M, Rives S, Martinez A, Bosch F, et al. Clinical impact of the differentiation profile assessed by immunophenotyping in patients with diffuse large B-cell lymphoma. Blood 2003;101:78\u201384.","journal-title":"Blood"},{"key":"181_CR18","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.lungcan.2007.09.010","volume":"60","author":"I.I. Na","year":"2008","unstructured":"Na, II, Cheon GJ, Choe DH, Byun BH, Kang HJ, Koh JS, et al. Clinical significance of 18F-FDG uptake by N2 lymph nodes in patients with resected stage IIIA N2 non-small-cell lung cancer: a retrospective study. Lung Cancer 2008;60:69\u201374.","journal-title":"Lung Cancer"},{"key":"181_CR19","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s00277-005-0060-6","volume":"85","author":"Y.H. Park","year":"2006","unstructured":"Park YH, Lee JJ, Ryu MH, Kim SY, Kim DH, Do YR, et al. Improved therapeutic outcomes of DLBCL after introduction of rituximab in Korean patients. Ann Hematol 2006;85:257\u2013262.","journal-title":"Ann Hematol"},{"key":"181_CR20","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1200\/JCO.1999.17.4.1244","volume":"17","author":"B.D. Cheson","year":"1999","unstructured":"Cheson BD, Horning SJ, Coiffier B, Shipp MA, Fisher RI, Connors JM, et al. Report of an international workshop to standardize response criteria for non-Hodgkin\u2019s lymphomas. NCI Sponsored International Working Group. J Clin Oncol 1999;17:1244.","journal-title":"J Clin Oncol"},{"key":"181_CR21","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","volume":"53","author":"E. Kaplan","year":"1958","unstructured":"Kaplan E, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457\u2013481.","journal-title":"J Am Stat Assoc"},{"key":"181_CR22","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.1002\/cncr.10583","volume":"94","author":"R.B. Wilder","year":"2002","unstructured":"Wilder RB, Rodriguez MA, Medeiros LJ, Tucker SL, Ha CS, Romaguera JE, et al. International prognostic index-based outcomes for diffuse large B-cell lymphomas. Cancer 2002;94:3083\u20133088.","journal-title":"Cancer"},{"key":"181_CR23","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1200\/JCO.2005.02.4786","volume":"24","author":"I.S. Lossos","year":"2006","unstructured":"Lossos IS, Morgensztern D. Prognostic biomarkers in diffuse large B-cell lymphoma. J Clin Oncol 2006;24:995\u20131007.","journal-title":"J Clin Oncol"},{"key":"181_CR24","doi-asserted-by":"crossref","first-page":"2797","DOI":"10.1200\/JCO.2005.07.155","volume":"23","author":"A. Lopez-Guillermo","year":"2005","unstructured":"Lopez-Guillermo A, Colomo L, Jimenez M, Bosch F, Villamor N, Arenillas L, et al. Diffuse large B-cell lymphoma: clinical and biological characterization and outcome according to the nodal or extranodal primary origin. J Clin Oncol 2005;23:2797\u20132804.","journal-title":"J Clin Oncol"},{"key":"181_CR25","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0360-3016(00)00597-6","volume":"48","author":"K. Sasai","year":"2000","unstructured":"Sasai K, Yamabe H, Kokubo M, Shibata T, Oya N, Nagata Y, et al. Head-and-neck stages I and II extranodal non-Hodgkin\u2019s lymphomas: real classification and selection for treatment modality. Int J Radiat Oncol Biol Phys 2000;48:153\u2013160.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"181_CR26","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1200\/JCO.1987.5.6.875","volume":"5","author":"M.K. Gospodarowicz","year":"1987","unstructured":"Gospodarowicz MK, Sutcliffe SB, Brown TC, Chua T, Bush RS. Patterns of disease in localized extranodal lymphomas. J Clin Oncol 1987;5:875\u2013880.","journal-title":"J Clin Oncol"},{"key":"181_CR27","first-page":"1431","volume":"45","author":"J.A. Thie","year":"2004","unstructured":"Thie JA. Understanding the standardized uptake value, its methods, and implications for usage. J Nucl Med 2004;45:1431\u20131434.","journal-title":"J Nucl Med"},{"key":"181_CR28","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1056\/NEJMoa011795","volume":"346","author":"B. Coiffier","year":"2002","unstructured":"Coiffier B, Lepage E, Briere J, Herbrecht R, Tilly H, Bouabdallah R, et al. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. N Engl J Med 2002;346:235\u2013242.","journal-title":"N Engl J Med"}],"container-title":["Annals of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12149-008-0181-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12149-008-0181-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12149-008-0181-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T20:59:08Z","timestamp":1589057948000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12149-008-0181-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,10]]},"references-count":28,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2008,10]]}},"alternative-id":["181"],"URL":"https:\/\/doi.org\/10.1007\/s12149-008-0181-9","relation":{},"ISSN":["0914-7187","1864-6433"],"issn-type":[{"value":"0914-7187","type":"print"},{"value":"1864-6433","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,10]]}}}